Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer
Status:
Recruiting
Trial end date:
2024-08-31
Target enrollment:
Participant gender:
Summary
This is a single arm Phase II study, in which 6 cycles of durvalumab with chemotherapy
(Etoposide and Cisplatin) and durvalumab followed by Sequential radiotherapy for limited
stage small cell lung cancer.